Ligand shareholders re-elect all eight directors, ratify auditor, and approve say-on-pay

LIGAND PHARMACEUTICALS INC

All eight director nominees elected, with each receiving >15.5M votes for (excluding broker non-votes).
Ratification of Ernst & Young as independent auditor for FY2025 passed with 17.27M votes for.
Non-binding advisory vote on named executive officer compensation approved with 15.58M votes for.
Broker non-votes totaled 1.36M on director elections and say-on-pay; none on auditor ratification.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.